Sentences with phrase «increased median survival»

«We increased median survival time in animals by 40 %, which gives us enough evidence to go on to human clinical trials,» Belcher says.

Based on recent information on the mechanisms of chemotherapy, a team of researchers of the McGill University Health Centre (MUHC) developed a new clinical approach to increase the efficiency of treatment in glioblastomas that increased the median survival to 22 months — bringing much needed hope to those affected by this aggressive disease.

Researchers developed a new clinical approach to increase the efficiency of treatment that increased the median survival to 22 months — bringing much needed hope to those affected by this aggressive disease.

Median survival time after surgery alone is reported to be 2 - 3 months, with the addition of chemotherapy increasing the median survival time to 4 - 6 months.

Not exact matches

MicroMentor reports that participating businesses had a 75 percent increase in median annual business sales and an 87 percent survival rate year over year.

Brahmer emphasizes that the relatively small increase in median survival time with the use of the new immunotherapy drugs may be somewhat misleading in terms of overall impact of the medicines.

Median progression - free survival for the 13 patients who had a decrease in the number of CTCs with ALK copy number gain was 14.0 months, while the median progression - free survival for the 16 patients who had stable or increased numbers of CTCs with ALK copy number gain was 6.1 mMedian progression - free survival for the 13 patients who had a decrease in the number of CTCs with ALK copy number gain was 14.0 months, while the median progression - free survival for the 16 patients who had stable or increased numbers of CTCs with ALK copy number gain was 6.1 mmedian progression - free survival for the 16 patients who had stable or increased numbers of CTCs with ALK copy number gain was 6.1 months.

Median progression - free survival, which increased by three months in patients receiving therapy, was statistically significant.

In the most recent results of the trial, treatment increased median overall survival by two months in patients treated according to protocol.

As of April 2015, with a median follow up of 30.1 months, the media progression free survival was 19.1 months and the median overall survival had increased to 32.1 months.

«We report much higher therapeutic efficacy in preclinical brain tumor models using the combination of both therapies, leading to an increase in median survival,» Lowenstein says.

Some patients given both treatments lived significantly longer (years) than expected, while the overall median survival increased by 59 % (2.6 months).

The data reported today show continued increases in median event - free survival and muscle function scores as well as achievement of developmental milestones.

The median survival was increased by 2.5 months in the TEMODAR arm.

Quality of life was significantly higher in participants randomized to the intervention group, who demonstrated a statistically and clinically meaningful increase in QOL at 12 weeks (P <.05 using the nonparametric Wilcoxon test).31, 32 Median survival was almost 5 months longer in the intervention group.

Dendreon's study of 512 men demonstrated that when compared to a placebo, Provenge increased three - year survival by 38 percent and extended median overall survival by 4.1 months.

Even at the lower, suboptimal 8 - μg / kg dose level, IMGN632 increased the lifespan of the animals by 263 % compared with vehicle treatment (median survival, 102 vs 28 days, respectively).

The most important measurement for CF Canada is the increase in median age of survival for those born with CF the current median reported in the 2014 CF Canada Registry is 51.8 years of age versus 50.9 years of age in 2013 and 47.0 in 2008.

In the 50 % of cats that showed at least some response to therapy, median survival time increased to 150 to 180 days as opposed to 75 to 86 days in the 50 % that did not respond.

In the 50 % of cats that showed at least some response to therapy, median survival time increased to 150 - 180 days as opposed to 75 - 86 days in the 50 % that did not respond.